Literature DB >> 9264265

Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development.

B A Roelen1, M A van Rooijen, C L Mummery.   

Abstract

ALK-1 is a type I serine/threonine kinase receptor for members of the TGF-beta superfamily of growth factors; its endogenous ligand is not known. In this study, we have analyzed the temporal and spatial expression pattern of ALK-1 mRNA in mouse embryos from the one-cell zygote until 12.5 dpc using RT-PCR and in situ hybridization. ALK-1 mRNA was first detected in the embryo at 6.5 dpc. From 7.5-8.5 dpc expression was highest at sites of vasculogenesis in both the embryonic and extraembryonic part of the conceptus, in trophoblast giant cells, and in the endothelial lining of the blood vessels in the decidua. From 9.5-12.5 dpc, ALK-1 was found to be expressed in several different tissues and organs, but was highest in blood vessels, mesenchyme of the lung, submucosal layer of the stomach and intestines, and at specific sites of epithelial-mesenchymal interactions. Its expression pattern suggests that ALK-1 is a type I receptor for TGF-beta1 in the developing mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264265     DOI: 10.1002/(SICI)1097-0177(199708)209:4<418::AID-AJA9>3.0.CO;2-L

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  35 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement.

Authors:  B S Jacobson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.

Authors:  Jinyong Luo; Min Tang; Jiayi Huang; Bai-Cheng He; Jian-Li Gao; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qing Luo; Qiong Shi; Bing-Qiang Zhang; Yang Bi; Xiaoji Luo; Wei Jiang; Yuxi Su; Jikun Shen; Stephanie H Kim; Enyi Huang; Yanhong Gao; Jian-Zhong Zhou; Ke Yang; Hue H Luu; Xiaochuan Pan; Rex C Haydon; Zhong-Liang Deng; Tong-Chuan He
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

4.  Heterogeneity amongst splenic stromal cell lines which support dendritic cell hematopoiesis.

Authors:  Geneviève Despars; Helen C O'Neill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

Review 5.  Developmental angiogenesis of the central nervous system.

Authors:  Michael R Mancuso; Frank Kuhnert; Calvin J Kuo
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

6.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

7.  Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1.

Authors:  Eva M Garrido-Martin; Francisco J Blanco; Africa Fernandez-L; Carmen Langa; Calvin P Vary; Ursula E Lee; Scott L Friedman; Luisa M Botella; Carmelo Bernabeu
Journal:  BMC Mol Biol       Date:  2010-06-29       Impact factor: 2.946

8.  Expression levels of endoglin distinctively identify hematopoietic and endothelial progeny at different stages of yolk sac hematopoiesis.

Authors:  Luciene Borges; Michelina Iacovino; Naoko Koyano-Nakagawa; June Baik; Daniel J Garry; Michael Kyba; Rita C R Perlingeiro
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

9.  Signaling through Tgf-beta type I receptor Alk5 is required for upper lip fusion.

Authors:  Wai-Yee Li; Marek Dudas; Vesa Kaartinen
Journal:  Mech Dev       Date:  2008-06-11       Impact factor: 1.882

10.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.

Authors:  Sara I Cunha; Evangelia Pardali; Midory Thorikay; Charlotte Anderberg; Lukas Hawinkels; Marie-José Goumans; Jasbir Seehra; Carl-Henrik Heldin; Peter ten Dijke; Kristian Pietras
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.